Company page

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. (VRDN) is a publicly traded company based in the United States, specializing in innovative therapies. With a market capitalization of approximately $2.13 billion, Viridian focuses on developing treatments for serious diseases. The company is committed to advancing its research and development efforts to improve patient outcomes.